[Focal therapy for prostate cancer in Germany - 2014 status]

A Roosen1, R Ganzer, B Hadaschik

  • 1Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Klinikum Großhadern, Marchioninistraße 15, 81377, München, Deutschland, alexander.roosen@med.uni-muenchen.de.

Der Urologe. Ausg. A
|June 20, 2014
PubMed
Summary

Focal therapy (FT) offers a middle ground for localized low-risk prostate cancer (PCa), balancing overtreatment risks and active surveillance (AS) limitations. Patient acceptance of FT is high, pending study outcomes.

Related Concept Videos